Mechanisms underlying relaxation of rabbit aorta by BAY 41-2272, a nitric oxide-independent soluble guanylate cyclase activator

被引:38
|
作者
Priviero, FBM [1 ]
Baracat, JS [1 ]
Teixeira, CE [1 ]
Claudino, MA [1 ]
De Nucci, G [1 ]
Antunes, E [1 ]
机构
[1] UNICAMP, Fac Med Sci, Dept Pharmacol, BR-13084971 Campinas, SP, Brazil
关键词
aorta; BAY; 41-2272; IH-[1,2,4]oxadiazolo[4, 3-a]quinoxalin-1-one; nitric oxide; sildenafil; soluble guanylate cyclase;
D O I
10.1111/j.1440-1681.2005.04262.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. The compound BAY 41-2272 (5-cyclopropyl-2-[1-(2fluoro-benzyi)-1H-pyrazolo[3,4-b]pyridin-3-yl]-pyrimidin-4- ylamine) has been described as a potent, nitric oxide (NO)independent, stimulator of soluble guanylate cyclase. In the present study, the mechanisms underlying the relaxant effect of BAY 41-2272 in endothelium-intact and -denuded precontracted rabbit aortic rings were investigated. 2. Male New Zealand white rabbits were anaesthetized with pentobarbital sodium. Aortic rings were transferred to 10 mL organ baths containing oxygenated and warmed Krebs' solution. Tissues were connected to force-displacement transducers and changes in isometric force were recorded. Aortic rings were precontracted submaximally with phenylephrine (1 mu mol/L). 3. The addition of BAY 41-2272 (0.01-10 mu mol/L) to the organ bath produced concentration-dependent relaxations of the aortic rings with a higher potency in endothelium-intact (pEC(50) 6.59 +/- 0.05) compared with endothelium-denuded (pEC(50) 6.19 +/- 0.04; P < 0.05) preparations. No differences in maximal responses were observed in either preparation. The NO synthesis inhibitor N-G-nitro-L-arginine methyl ester (100 mu mol/L) produced a 2.1-fold rightward shift in endothelium-intact (P < 0.01) rings, but had no effect in endothelium-denuded rings. The soluble guanylate cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ; 1 mu mol/L) caused significant rightward shifts of the concentration-response curves to BAY 41-2272 of 4.9- and 2.6-fold in endothelium-intact and -denuded rings, respectively. The phosphodiesterase-5 inhibitor sildenafil (0.1 mu mol/L) significantly potentiated the relaxant effects of BAY 41-2272 in both endothelium-intact and -denuded rings. 4. At 1 mu mol/L, BAY 41-2272 significantly elevated the aortic cGMP content above basal levels in both endothelium-intact and -denuded rings. Furthermore, ODQ reduced BAY 41-2272-elicited increases in cGMP content by 17 and 90% in endothelium-intact and -denuded rings, respectively (P < 0.01). 5. In conclusion, BAY 41-2272 potently relaxes endothelium-intact and -denuded rabbit aortic rings. The basal release of endothelium-derived NO enhances BAY 41-2272-induced relaxations, suggesting a synergistic effect of BAY 412272 and NO on soluble guanylate cyclase. In addition, the endothelium-independent relaxation involves both GMP-dependent and -independent mechanisms.
引用
收藏
页码:728 / 734
页数:7
相关论文
共 50 条
  • [21] Stimulation of soluble guanylyl cyclase by BAY 41-2272 relaxes anococcygeus muscle: Interaction with nitric oxide
    Teixeira, CE
    Priviero, FBM
    Claudino, MA
    Baracat, JS
    De Nucci, G
    Webb, RC
    Antunes, E
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 530 (1-2) : 157 - 165
  • [22] Increased cyclic guanosine monophosphate synthesis and calcium entry blockade account for the relaxant activity of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in the rabbit penile urethra
    Toque, Haroldo A. Flores
    Antunes, Edson
    Teixeira, Cleber E.
    De Nucci, Gilberto
    UROLOGY, 2008, 72 (03) : 711 - 715
  • [23] Inhibition of phosphodiesterase type 5 by the activator of nitric oxide-sensitive guanylyl cyclase BAY 41-2272
    Mullershausen, F
    Russwurm, M
    Friebe, A
    Koesling, D
    CIRCULATION, 2004, 109 (14) : 1711 - 1713
  • [24] BAY 41-2272, an activator of nitric oxide-independent site of soluble guanylate cyclase, induces gp91phox gene expression and activates the human NADPH oxidase system in monocytic THP-1 cells.
    de Oliveira, Edgar
    Rehder, Jussara
    Thomazzi, Sara
    Condino, Antonio
    CLINICAL IMMUNOLOGY, 2006, 119 : S136 - S137
  • [25] Increased sensitivity to the NO-independent soluble guanylyl cyclase stimulator BAY 41-2272 in aorta from eNOS -/- mice
    Teixeira, Cleber E.
    Priviero, Fernanda B.
    Zemse, Sailprasad M.
    Hilgers, Rob H.
    Webb, R. Clinton
    HYPERTENSION, 2006, 48 (04) : E93 - E93
  • [26] Maternal and fetal effects of bay 41-2272, a direct soluble guanylate cyclase activator, in a model of preeclampsia and intra uterine growth restriction
    Ladaique, Anais
    Annabelle, Le Roch
    Storme, Laurent
    Deruelle, Philippe
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2009, 201 (06) : S12 - S12
  • [27] LONG-TERM ADMINISTRATION OF THE NITRIC OXIDE-INDEPENDENT SOLUBLE GUANYLATE CYCLASE ACTIVATOR BAY PREVENTS RAT DETRUSOR OVERACTIVITY
    D'Ancana, Carlos
    Antunes, Edson
    Monica, Fabiola
    Cohen, David
    Reges, Ricardo
    JOURNAL OF UROLOGY, 2010, 183 (04): : E174 - E174
  • [28] The anti-aggregating effect of BAY 41-2272, a stimulator of soluble guanylyl cyclase, requires the presence of nitric oxide
    Roger, Severine
    Badier-Commander, Cecile
    Paysant, Jerome
    Cordi, Alex
    Verbeuren, Tony J.
    Feletou, Michel
    BRITISH JOURNAL OF PHARMACOLOGY, 2010, 161 (05) : 1044 - 1058
  • [29] BAY 41-2272: A stimulator of soluble guanylyl cyclase induces nitric oxide-dependent penile erection in vivo
    Bischoff, E
    Schramm, M
    Straub, A
    Feurer, A
    Stasch, JP
    UROLOGY, 2003, 61 (02) : 464 - 467
  • [30] BAY 41-2272, a Soluble Guanylate Cyclase Stimulator, Relaxes Isolated Human Ureter in a Standardized In Vitro Model
    Miyaoka, Ricardo
    Mendes, Camila
    Schenka, Andre
    Gonzalez, Paulo Gabriel
    de Nucci, Gilberto
    Antunes, Edson
    Monga, Manoj
    D'Ancona, Carlos Arturo Levi
    Monica, Fabiola Zakia
    UROLOGY, 2014, 83 (01) : 256.e1 - 256.e7